University of Colorado Colorado Springs
Colorado Springs, Colorado, 80918, United States
NCT Number: NCT07391254
This randomized, placebo-controlled double blinded study examined whether placebo, low- or high dose omega 3 fatty acid supplementation had associations with mental health symptoms and vitamin D status in college students aged 18-27.
Looking for future studies?
Notify Me18 year–27 year
All sexes
Interventional
Not applicable
Colorado Springs, Colorado, 80918, United States
A 3-arm randomized design was employed where participants took 2 pills daily for 90 days. The first arm was a placebo, second arm was a low dose omega 3 and third arm was high dose omega 3. Mental health outcomes were measured using the GAD 7 questionnaire that measured anxiety, PHQ-9 which measured depression, and MSQ (Medical Symptoms Questionnaire) that assessed overall bodily symptoms. Vitamin D levels were also assessed as a secondary outcome.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Placebo
700 mg/day omega 3 fatty acids
2150 mg/day omega 3 fatty acids
Time frame: Baseline to end of intervention (90 days)
GAD-7 (Summed 0-21 with higher scores indicating more anxiety)
Time frame: Baseline to end of intervention (90 days)
PHQ-9 (Summed for a score of 0-27, the higher the score the more depression)
Time frame: Baseline to end of intervention (90 days)
serum 25-hydroxyvitamin D
Time frame: Baseline to end of intervention (90 days)
Medical Symptoms Questionnaire (MSQ), summed score 0-100, the lower the score the better health. Optimal health is 10 or less
University of Colorado, Colorado Springs
Other
Impact of Omega-3 Supplementation on Omega-3 Status, Vitamin D and Mood in College Students
Acronym: OMEGA-MH
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07621731
Aberrant Motor Behavior in Dementia, Aggression
Ngoma, Eastern Province, Rwanda
View Trial DetailsNCT06392100
Anxiety, Anxiety Disorders
Taipei, Taiwan
View Trial DetailsNCT06475690
Anesthesia, General, Anxiety Disorders
Chongqing, Chongqing Municipality, China
View Trial DetailsNCT07038109
Adaptation, Psychological, Anxiety
Samsun, Turkey (Türkiye)
View Trial Details